![Taylor Harris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Taylor Harris
Direktor/Vorstandsmitglied bei
PROCEPT BIOROBOTICS CORPORATION
Vermögen: 3 Mio $ am 30.06.2026
Profil
Taylor C.
Harris is currently an Independent Director at PROCEPT BioRobotics Corp.
since 2020, a Director at Establishment Labs Holdings, Inc. starting in 2026, and Chief Financial Officer at Synthego Corp.
since 2022.
Former roles include Chief Executive Officer at Cutera, Inc. in 2023; Director at HealthCor Catalio Acquisition Corp.; Director at Endologix LLC from 2020 to 2023; Director at Omada Health, Inc. from 2021 to 2023; Vice President-Healthcare Investment Banking at JPMorgan Chase & Co. from 1998 to 2010; Associate Analyst at JPMorgan Securities LLC from 2009 to 2010; Chief Financial Officer at MyoKardia, Inc. from 2018 to 2020; Chief Financial Officer & Vice President at Thoratec Corp.
from 2014 to 2015; and Chief Financial Officer & Senior Vice President at ZELTIQ Aesthetics, Inc. from 2016 to 2017.
Education includes an undergraduate degree from The University of North Carolina at Chapel Hill, conferred in 1998.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.06.2026 | 137 565 ( 0,24 % ) | 3 Mio $ | 30.06.2026 | |
| 24.06.2026 | 3 230 ( 0,01 % ) | 277 166 $ | 30.06.2026 |
Aktive Positionen von Taylor Harris
| Unternehmen | Position | Beginn |
|---|---|---|
| PROCEPT BIOROBOTICS CORPORATION | Direktor/Vorstandsmitglied | 01.12.2020 |
| ESTABLISHMENT LABS HOLDINGS INC. | Direktor/Vorstandsmitglied | 24.06.2026 |
Synthego Corp.
 Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Finanzdirektor/CFO | 01.09.2022 |
Ehemalige bekannte Positionen von Taylor Harris
| Unternehmen | Position | Ende |
|---|---|---|
| OMADA HEALTH, INC. | Direktor/Vorstandsmitglied | 01.08.2023 |
| ENDOLOGIX, INC. | Direktor/Vorstandsmitglied | 01.08.2023 |
| MYOKARDIA, INC. | Finanzdirektor/CFO | 01.11.2020 |
| ZELTIQ AESTHETICS INC | Finanzdirektor/CFO | 01.04.2017 |
| THORATEC CORPORATION | Finanzdirektor/CFO | 02.10.2015 |
Ausbildung von Taylor Harris
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Thoratec Corp.
 Thoratec Corp. Medical SpecialtiesHealth Technology Manufactures and distributes circulatory support devices for heart failure patients | Health Technology |
Endologix LLC
 Endologix LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for the interventional treatment of vascular disease | Health Technology |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Cutera, Inc.
 Cutera, Inc. Medical SpecialtiesHealth Technology Develops medical devices for the treatment of dermatological problems | Health Technology |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
ZELTIQ Aesthetics, Inc.
 ZELTIQ Aesthetics, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company that develops non-invasive procedures for the reduction of unwanted fat tissue | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
PROCEPT BioRobotics Corp.
 PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omada Health, Inc.
 Omada Health, Inc. Internet Software/ServicesTechnology Services Operates as a virtual care program that pairs with a care team and resources to help your health goals | Technology Services |
Establishment Labs Holdings, Inc.
 Establishment Labs Holdings, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures medical products | Health Technology |
HealthCor Catalio Acquisition Corp.
 HealthCor Catalio Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
